2023-2032 Global Biologics and Biosimilars Market Research by Type, End-Use and Region (COVID-19 Version)

Summary

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:

Key Companies:
NatureWorks
Braskem
BASF
Arkema
DuPont
Novamont
Corbion
Metabolix
PSM
PolyOne
Biome Bioplastics
Biomer
FKuR
Trellis Bioplastics
Kingfa
Cardia Bioplastics
Grabio
MHG
Myriant
Mitsubishi
Zhejiang Hisun Biomaterials

Key Types
Bio-PET
PHA
Bio-PE
Starch Blends
PLA
Others

Key End-Use
Packing Industry
Automotive Industry
Bottles manufacturing
Others

This report can be dispatched within 24-48 Hours.

Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBiologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Figure Global Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
2.3 Global Production by Type
Table Global Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
2.4 Global Consumption by End-Use
Table Global Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
2.5 Global Consumption by Region
Table Global Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Figure Europe Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
3.3 Europe Production by Type
Table Europe Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Europe Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
3.4 Europe Consumption by End-Use
Table Europe Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
3.5 Europe Consumption by Region
Table Europe Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Figure America Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
4.3 America Production by Type
Table America Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure America Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
4.4 America Consumption by End-Use
Table America Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
4.5 America Consumption by Region
Table America Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Figure Asia Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
5.3 Asia Production by Type
Table Asia Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Asia Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
5.4 Asia Consumption by End-Use
Table Asia Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
5.5 Asia Consumption by Region
Table Asia Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Figure Oceania Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
6.4 Oceania Consumption by End-Use
Table Oceania Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
6.5 Oceania Consumption by Region
Table Oceania Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Figure Africa Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
7.3 Africa Production by Type
Table Africa Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Africa Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
7.4 Africa Consumption by End-Use
Table Africa Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
7.5 Africa Consumption by Region
Table Africa Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Biologics and Biosimilars Production Forecast
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
8.2 Global Biologics and Biosimilars Forecast by Type
Table Global Biologics and Biosimilars Revenue by Type, 2020E-2025F (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2025 (Million USD)
8.3 Global Biologics and Biosimilars Forecast by End-Use (2020E-2025F)
Table Global Biologics and Biosimilars Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2025 (Million USD)
8.4 Global Biologics and Biosimilars Forecast by Region (2020E-2025F)
Table Global Biologics and Biosimilars Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by Region in 2025 (Million USD)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 NatureWorks
9.1.1 NatureWorks Profile
Table NatureWorks Overview List
9.1.2 NatureWorks Products & Services
9.1.3 NatureWorks Company Dynamics & News
9.1.4 NatureWorks Business Operation Conditions
Table Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Braskem
9.2.1 Braskem Profile
Table Braskem Overview List
9.2.2 Braskem Products & Services
9.2.3 Braskem Company Dynamics & News
9.2.4 Braskem Business Operation Conditions
Table Business Operation of Braskem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 BASF
9.3.1 BASF Profile
Table BASF Overview List
9.3.2 BASF Products & Services
9.3.3 BASF Company Dynamics & News
9.3.4 BASF Business Operation Conditions
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Arkema
9.4.1 Arkema Profile
Table Arkema Overview List
9.4.2 Arkema Products & Services
9.4.3 Arkema Company Dynamics & News
9.4.4 Arkema Business Operation Conditions
Table Business Operation of Arkema (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 DuPont
9.5.1 DuPont Profile
Table DuPont Overview List
9.5.2 DuPont Products & Services
9.5.3 DuPont Company Dynamics & News
9.5.4 DuPont Business Operation Conditions
Table Business Operation of DuPont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Novamont
9.6.1 Novamont Profile
Table Novamont Overview List
9.6.2 Novamont Products & Services
9.6.3 Novamont Company Dynamics & News
9.6.4 Novamont Business Operation Conditions
Table Business Operation of Novamont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Corbion
9.7.1 Corbion Profile
Table Corbion Overview List
9.7.2 Corbion Products & Services
9.7.3 Corbion Company Dynamics & News
9.7.4 Corbion Business Operation Conditions
Table Business Operation of Corbion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Metabolix
9.8.1 Metabolix Profile
Table Metabolix Overview List
9.8.2 Metabolix Products & Services
9.8.3 Metabolix Company Dynamics & News
9.8.4 Metabolix Business Operation Conditions
Table Business Operation of Metabolix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 PSM
9.9.1 PSM Profile
Table PSM Overview List
9.9.2 PSM Products & Services
9.9.3 PSM Company Dynamics & News
9.9.4 PSM Business Operation Conditions
Table Business Operation of PSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 PolyOne
9.10.1 PolyOne Profile
Table PolyOne Overview List
9.10.2 PolyOne Products & Services
9.10.3 PolyOne Company Dynamics & News
9.10.4 PolyOne Business Operation Conditions
Table Business Operation of PolyOne (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Biome Bioplastics
9.11.1 Biome Bioplastics Profile
Table Biome Bioplastics Overview List
9.11.2 Biome Bioplastics Products & Services
9.11.3 Biome Bioplastics Company Dynamics & News
9.11.4 Biome Bioplastics Business Operation Conditions
Table Business Operation of Biome Bioplastics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Biomer
9.12.1 Biomer Profile
Table Biomer Overview List
9.12.2 Biomer Products & Services
9.12.3 Biomer Company Dynamics & News
9.12.4 Biomer Business Operation Conditions
Table Business Operation of Biomer (Sales Revenue, Cost, Gross Margin)
9.13 FKuR
9.13.1 FKuR Profile
Table FKuR Overview List
9.13.2 FKuR Products & Services
9.13.3 FKuR Company Dynamics & News
9.13.4 FKuR Business Operation Conditions
Table Business Operation of FKuR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Trellis Bioplastics
9.14.1 Trellis Bioplastics Profile
Table Trellis Bioplastics Overview List
9.14.2 Trellis Bioplastics Products & Services
9.14.3 Trellis Bioplastics Company Dynamics & News
9.14.4 Trellis Bioplastics Business Operation Conditions
Table Business Operation of Trellis Bioplastics (Sales Revenue, Cost, Gross Margin)
9.15 Kingfa
9.15.1 Kingfa Profile
Table Kingfa Overview List
9.15.2 Kingfa Products & Services
9.15.3 Kingfa Company Dynamics & News
9.15.4 Kingfa Business Operation Conditions
Table Business Operation of Kingfa (Sales Revenue, Cost, Gross Margin)
9.16 Cardia Bioplastics
9.16.1 Cardia Bioplastics Profile
Table Cardia Bioplastics Overview List
9.16.2 Cardia Bioplastics Products & Services
9.16.3 Cardia Bioplastics Company Dynamics & News
9.16.4 Cardia Bioplastics Business Operation Conditions
Table Business Operation of Cardia Bioplastics (Sales Revenue, Cost, Gross Margin)
9.17 Grabio
9.17.1 Grabio Profile
Table Grabio Overview List
9.17.2 Grabio Products & Services
9.17.3 Grabio Company Dynamics & News
9.17.4 Grabio Business Operation Conditions
Table Business Operation of Grabio (Sales Revenue, Cost, Gross Margin)
9.18 MHG
9.18.1 MHG Profile
Table MHG Overview List
9.18.2 MHG Products & Services
9.18.3 MHG Company Dynamics & News
9.18.4 MHG Business Operation Conditions
Table Business Operation of MHG (Sales Revenue, Cost, Gross Margin)
9.19 Myriant
9.19.1 Myriant Profile
Table Myriant Overview List
9.19.2 Myriant Products & Services
9.19.3 Myriant Company Dynamics & News
9.19.4 Myriant Business Operation Conditions
Table Business Operation of Myriant (Sales Revenue, Cost, Gross Margin)
9.20 Mitsubishi
9.20.1 Mitsubishi Profile
Table Mitsubishi Overview List
9.20.2 Mitsubishi Products & Services
9.20.3 Mitsubishi Company Dynamics & News
9.20.4 Mitsubishi Business Operation Conditions
Table Business Operation of Mitsubishi (Sales Revenue, Cost, Gross Margin)
9.21 Zhejiang Hisun Biomaterials
9.21.1 Zhejiang Hisun Biomaterials Profile
Table Zhejiang Hisun Biomaterials Overview List
9.21.2 Zhejiang Hisun Biomaterials Products & Services
9.21.3 Zhejiang Hisun Biomaterials Company Dynamics & News
9.21.4 Zhejiang Hisun Biomaterials Business Operation Conditions
Table Business Operation of Zhejiang Hisun Biomaterials (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Biologics and Biosimilars Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, 2015-2020E, by Companies, in USD
10.2 Regional Market Concentration
Figure Europe Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure America Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Asia Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Oceania Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Africa Biologics and Biosimilars Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Biologics and Biosimilars INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Biologics and Biosimilars INDUSTRY SUMMARY & CONCLUSION

List of Figure
Figure Europe Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBiologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Europe Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure America Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Asia Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Oceania Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
Figure Africa Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2025 (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by Region in 2025 (Million USD)